Treatment outcomes of patients with stage II pure endometrioid-type endometrial cancer: a Taiwanese Gynecologic Oncology Group (TGOG-2006) retrospective cohort study.

Hung-Chun FuJen Ruei ChenMin Yu ChenKeng-Fu Hsu Wen-Fang Cheng An Jen Chiang Yu Min KeYu Chieh ChenYin Yi ChangChia Yen HuangChieh Yi KangYuan Yee KanSheng Mou HsiaoMing Shyen Yen

Published in: Journal of gynecologic oncology (2018)

Different treatment modalities yield similar survival outcomes. Patients receiving SH with RT had lower locoregional recurrent with acceptable morbidity. Age and tumor grading remained significant predictors for survival among patients with FIGO 2009 stage II EEC.

Keyphrases

endometrial cancer
palliative care
combination therapy
replacement therapy
smoking cessation